TARGANTA THERAPEUTICS
Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious infections treated or acquired in hospitals and other institutional settings.
TARGANTA THERAPEUTICS
Industry:
Biopharma Health Care Pharmaceutical
Founded:
2005-12-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.targanta.com
Total Employee:
51+
Status:
Active
Contact:
973 290 6000
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
Google Maps LetsEncrypt SSL By Default IPv6 Cloudflare Hosting Cloudflare CDN Cloudflare Cloudflare DNS Cloudflare Network Error Logging Clicky
Stock Details
Investors List
Seaflower Ventures
Seaflower Ventures investment in Series C - Targanta Therapeutics
OrbiMed
OrbiMed investment in Series C - Targanta Therapeutics
Canadian Medical Discoveries Fund
Canadian Medical Discoveries Fund investment in Series C - Targanta Therapeutics
Brookside Capital
Brookside Capital investment in Series C - Targanta Therapeutics
Skyline Ventures
Skyline Ventures investment in Series C - Targanta Therapeutics
Radius Ventures
Radius Ventures investment in Series C - Targanta Therapeutics
Official Site Inspections
http://www.targanta.com
- Host name: 104.21.64.137
- IP address: 104.21.64.137
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Targanta Therapeutics"
Targanta Therapeutics - Corporate Overview
Targanta, Inc. is a biopharmaceutical company focused on developing and commercializing antibacterial agents. Targanta's latest-stage antibacterial drug, oritavancin, is a semisynthetic …See details»
Targanta Therapeutics Corporation - Wikipedia
Targanta Therapeutics Corporation was a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company also had operations in Indianapolis, Montreal and Toronto. Targanta completed its initial public offering on October 9, 2007 and traded on the Nasdaq market under the symbol: TARG. Targanta was acquired by The Medicines Company in 2009. See details»
Targanta Therapeutics - Crunchbase Company Profile …
Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious …See details»
Targanta Therapeutics - Corporate Mission
Homepage About Us. Corporate Mission; Corporate Overview; Compliance Program; Code of Conduct; Pipeline News People Careers Contact Us : Corporate Mission Targanta …See details»
Targanta Therapeutics - The Org
Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious infections treated or acquired in hospitals and other institutional settings. Industries. …See details»
Targanta Therapeutics Corp. - Drug pipelines, Patents, Clinical …
Explore Targanta Therapeutics Corp. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 9 news, and 9 literature, Disease Domain ...See details»
Targanta Therapeutics Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Targanta Therapeutics Corporation of Parsippany, NJ. Get the latest business insights from Dun & …See details»
Targanta Therapeutics - Funding, Financials, Valuation & Investors
Targanta Therapeutics is registered under the ticker NASDAQ:TARG . Their stock opened with $10.00 in its Oct 10, 2007 IPO. Stock Symbol NASDAQ:TARG ; Money Raised at IPO $57.5M; …See details»
Targanta Therapeutics - PitchBook
Targanta Therapeutics was acquired on 26-Feb-2009. Who acquired Targanta Therapeutics? Targanta Therapeutics was acquired by The Medicines Company. Data Transparency. Meet …See details»
Board of Directors | The Medicines Company - targanta.com
Melvin K. Spigelman has been a director since September 2005. Since January 2009, Dr. Spigelman has served as president and chief executive officer of the Global Alliance for TB …See details»
Organization | Targanta
Targanta Report issue. Contributed to NME For profit Phase 2. Founded: Cambridge MA United States (1997) Status: Acquired by The Medicines Company (2009 ...See details»
Targanta Therapeutics - Overview, News & Similar companies
Jul 18, 2022 Who is Targanta Therapeutics. Targanta Therapeutics Corporation is a biopharmaceutical company focused on developing and commercializing innovative antibiotics …See details»
Targanta Therapeutics Corporation | OSC
B. Targanta Therapeutics (Ontario) Inc. ("Targanta Ontario"), a corporation incorporated under the CBCA on December 22, 2005 with a head office in Toronto, Ontario (Targanta Ontario and …See details»
Targanta Therapeutics - Contacts, Employees, Board Members
Targanta Therapeutics is a biopharma Company. AI Content may contain mistakes and is not legal, financial or investment advice.See details»
Corporate Governance | The Medicines Company - targanta.com
Sound corporate governance principles are the foundation of investor confidence and trust. These principles are critical to maintaining The Medicines Company’s reputation as a company …See details»
Targanta Therapeutics: Hitting a Moving Target - Case - Faculty ...
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark …See details»
What is Targanta? Company Culture, Mission, Values
See what employees say it's like to work at Targanta. Salaries, reviews, and more - all posted by employees working at Targanta.See details»
Targenta - Main Page
[email protected] +358 41 7288443 Leija Yrityskeskus, Elannontie 3, 01510, Vantaa, FinlandSee details»
Targanta Therapeutics - Corporate Overview
Targanta's latest-stage antibacterial drug, oritavancin, is a semisynthetic glycopeptide with potent bactericidal activity against nearly all clinically relevant, difficult-to-treat Gram-positive …See details»